Geode Capital Management
NEPH icon

Geode Capital Management’s Nephros NEPH Stock Holding History

Geode Capital Management’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$251K Sell
70,263
-2,662
-4% -$8.66K ﹤0.01% 3842
2026
Q1 		$217K Sell
72,925
-1,703
-2% -$6.8K ﹤0.01% 3880
2025
Q4 		$364K Sell
74,628
-1,263
-2% -$6.45K ﹤0.01% 3710
2025
Q3 		$359K Sell
75,891
-17,296
-19% -$67.9K ﹤0.01% 3731
2025
Q2 		$381K Buy
93,187
+2,898
+3% +$7.74K ﹤0.01% 3640
2025
Q1 		$155K Buy
90,289
+5,439
+6% +$8.53K ﹤0.01% 3915
2024
Q4 		$124K Sell
84,850
-399
-0.5% -$608 ﹤0.01% 4044
2024
Q3 		$146K Buy
85,249
+7,214
+9% +$14.3K ﹤0.01% 4002
2024
Q2 		$165K Buy
78,035
+6,998
+10% +$15.1K ﹤0.01% 3984
2024
Q1 		$156K Hold
71,037
– – ﹤0.01% 4020
2023
Q4 		$245K Hold
71,037
– – ﹤0.01% 3864
2023
Q3 		$106K Sell
71,037
-6,307
-8% -$9.38K ﹤0.01% 4230
2023
Q2 		$120K Buy
77,344
+66,216
+595% +$97.7K ﹤0.01% 4266
2023
Q1 		$12.1K Sell
11,128
-231
-2% -$266 ﹤0.01% 4757
2022
Q4 		$12K Hold
11,359
– – ﹤0.01% 4827
2022
Q3 		$10K Hold
11,359
– – ﹤0.01% 4981
2022
Q2 		$17K Buy
11,359
+1,167
+11% +$3.15K ﹤0.01% 4945
2022
Q1 		$44K Buy
+10,192
New +$48.4K ﹤0.01% 4826

Other funds holding NEPH

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CC
Cornerstone Capital Palo Alto, California $1.12B AUM 28.84% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Geode Capital Management's NEPH Position: Q2 2026 in Review

Geode Capital Management reduced its Nephros (NEPH) stake by 3.7% in Q2 2026, selling an estimated $8.66K and leaving 70,263 shares worth $251K. The position accounts for ﹤0.01% of the portfolio, ranked #3842.

Geode Capital Management first reported a position in NEPH in Q1 2022 and has held it in 18 quarters since. The position peaked at $381K in Q2 2025. 29 funds tracked by Wall St. Rank hold NEPH as of Q2 2026.

  • Geode Capital Management held 70,263 shares of Nephros worth $251K as of Q2 2026.
  • Geode Capital Management sold 2,662 Nephros shares in Q2 2026, an estimated $8.66K.
  • Nephros made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3842 holding.
  • Geode Capital Management first reported a position in Nephros in Q1 2022 and has held it in 18 quarters since.
  • Geode Capital Management's Nephros position peaked at $381K in Q2 2025.
  • 29 funds tracked by Wall St. Rank held Nephros as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.